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Abstract 
It was found that 3-amino-substituted 5-aminopyrazoles could be effectively prepared via 
hydrolytic decarboxylation of the corresponding 3,5-diaminopyrazole-4-carboxylates 5 
under microwave irradiation. The reactions required short time (4 min) and were 
successfully reproduced in a larger scale and under conventional heating mimicking the 
microwave heating pattern. X-ray crystallography identified two different types of 
tautomers in crystals of related 5-aminopyrazoles with p-toluidyl and p-anisidyl moieties at 
the position 3, respectively.  
 
  
1. Introduction 
5-Aminopyrazoles have been well recognised as biologically active compounds and efficient 
building blocks for the construction of fused heterocyclic molecules of high medicinal value.1  
Recent studies demonstrated an interesting biological profile for 3,5-diaminopyrazole (1) 
(Fig. 1).2  Hoffmann-La Roche patented 5-amino-3-arylaminopyrazoles (e.g. 2) as antiviral 
agents, particularly useful for the treatment of hepatitis C virus infection.3 Some 3-amino-
substituted 5-aminopyrazoles of general structure 3 were also mentioned in patents as 
building blocks for the construction of bioactive compounds.4  Surprisingly, information on 
the synthesis of such non-symmetrically substituted 3,5-diaminopyrazoles is rather scarce.  
The methods earlier developed for the preparation of 3-amino-substituted 5-
aminopyrazoles 3 are limited to heterocyclizations of N-substituted cyanoacetimidate esters 
or amides of cyanothioacetic acid in their reactions with hydrazine.5,6 The main drawbacks 
of these synthetic approaches included relatively difficult accessibility of starting materials 
and low yields.3,5,6  
In our program on the synthesis of new purine-like heterocycles7 we required 3-
amino-substituted 5-aminopyrazoles 3 as synthons for further reactions.8 That led us to the 
development of the described here practical method for the synthesis of compounds 3.  Our 
interest towards prototropic tautomerism in azoles9 prompted us to investigate this 
phenomenon viz. tautomeric preferences in the representative compounds 3 using X-ray 
crystallography.   
 
Figure 1. Selected bioactive 3,5-diaminopyrazoles.  
  
2 Results and discussion 
2.1 Synthesis of 3-amino-substituted 5-aminopyrazoles (3) 
For the synthesis of 3-amino-substituted 5-aminopyrazoles 3 we decided to employ readily 
accessible 3-amino-substituted 5-aminopyrazole-4-carboxylates 5, which can be 
conveniently prepared in good yields from 2-cyano-3-methylthioacrylates 4 using the 
previously described method (Scheme 1).10 The hydrolytic decarboxylation of 5 was 
suggested as a potential route to 3-amino-substituted 5-aminopyrazoles 3. 
 
 
Scheme 1. 
 
The initial optimization of reaction conditions for the synthesis 3 was performed 
using ethyl 5-amino-3-phenylaminopyrazole-4-carboxylate (5a) (Table 1). The reaction 
proceeded under microwave irradiation to form product 3a in 2 mL of 2M aqueous solution 
of NaOH at 150 °C for 30 sec (Entry 1). Increasing the time of reaction (Entries 1-6) led to the 
further improvement of yields with the yield of 81% achieved at 150 °C in 4 min (Entry 5). 
Altering the concentration of NaOH did not led to an improvement in isolated yields (Entries 
7 and 8). Conducting the reaction in 2M aqueous solution of K2CO3 or Na2CO3 led to lower 
yields (Entries 9 and 10), while changing the base to an acid (Entry 11) resulted in the 
isolation of the starting material 5a only.  
It should be noted that attempts to carry out the reaction under reflux for 12 h using 
2M NaOH solution did not lead to the isolation of 3a but rather to the recovery of starting 
material 5a. However, an attempt to carry out the decarboxylation reaction of 5a in 2M 
NaOH, imitating the optimised microwave irradiation conditions in the Monowave 50 
reactor (Anton Paar), using sealed vessels under fast conventional heating successfully led 
to the formation of equally pure 3a in 75% yield. Therefore, there was minimal (if any) 
contribution of non-thermal microwave effects in promoting this reaction.  
With the optimized conditions in hand, we decided to explore the scope of the 
reaction with a diverse library of 3-amino-substituted 5-aminopyrazole-4-carboxylates (5) as 
substrates. Compounds 5 were prepared according to the recently developed microwave-
assisted approach.10 Subsequently, the base-catalysed decarboxylation of ethyl 5-
aminopyrazole-4-carboxylates 5 under microwave irradiation was found to proceed 
efficiently with the formation of desired products 3a-3l in yields up to 85% (Table 2). A 
variety of arylamino and arylalkylamino substituents on the pyrazole ring was well tolerated 
with exclusive formation of compounds 3, which were isolated in high purity via simple 
filtration. Using optimized conditions, we also attempted to carry out this reaction with 
methyl 3,5-diaminopyrazole-4-carboxylates 5. For comparison purposes, 3a, 3h and 3j were 
successfully prepared from the corresponding methyl esters 5. In all cases, the hydrolytic 
decarboxylation of methyl and ethyl esters was efficiently performed in both 0.325 mmol 
and 3.25 mmol scales with similar outcomes (Table 2).  
The structure assignments for the prepared 3,5-diaminopyrazoles 3 were made 
based on their spectral data. When compared with the spectra of reported staring 
materials,10 we observed the disappearance of the characteristic 1H NMR and 13C NMR 
signals of the ethoxycarbonyl and methoxycarbonyl groups in addition to the absence of a 
C=O band in the IR spectra. Additionally, a signal assigned to H-4 atom of the pyrazole ring 
appeared in 1H NMR spectra of 3 at 4.62-5.07 ppm.  
Annular prototropic tautomerism is an interesting phenomenon, which has been 
widely investigated in aminopyrazoles.11 In the 1H NMR spectra of the prepared compounds, 
signals of protons of the exocyclic amino groups, C-H proton on the pyrazole ring and 
aromatic ring protons of 5-amino-3-arylaminopyrazoles 3a-3k adjacent to the pyrazole ring 
appeared as broad signals. However, the tautomeric transformations were probably too fast 
to be detected on the 1H NMR time-scale under the experimental conditions and therefore 
the tautomers were indistinguishable. For the compound 3l, two tautomeric forms (KT = 1.3) 
were detected in the NMR spectra in DMSO solution with 1H-form of 5-amino-3-
phenethylaminopyrazole (3l) being predominant. Further study of the tautomeric 
preferences was performed on pyrazoles 3g and 3i using X-ray crystallography. While to a 
first approximation the molecular structures of 3g and 3i appeared to be similar, crucially 
the compounds crystallized in the form of different tautomers as discussed in detail below. 
 
Table 1. Optimization conditions for the synthesis of 5-amino-3-phenylaminopyrazole (3a)a 
 
Entry Base/Acid Temperature (°C) Time (min) Isolated yield (%) 
1 2M NaOH 150 0.5 43 
2 2M NaOH 150 1 40 
3 2M NaOH 150 2 76 
4 2M NaOH 150 3 80 
5 2M NaOH 150 4 81 
6 2M NaOH 150 5 72 
7 1M NaOH 150 4 71 
8 3M NaOH 150 4 64 
9 2M K2CO3 150 4 25 
10 2M Na2CO3 150 4 30 
11 2M HCl 150 4 0b 
a The reaction was performed using a Discover SP CEM microwave synthesizer with 0.325 
mmol of 5a in 2 mL of the specified base or acid. 
b Only starting material 5a was isolated.  
  
Table 2. Synthesis of 3-amino-substituted 5-aminopyrazoles (3) from 3,5-diaminopyrazole-4-
carboxylates (5)a  
 
Compound  Structure 
Yield (%) 
Mp (°C) 0.325 mmol 
scale 
3.25 mmol 
scale 
3a 
 
81 
74b 
68 
83b 
166-168c 
Lit.:6 166 
3b 
 
61 68 165-167c 
3c 
 
60 47 58-60c 
3d 
 
69 57 169-171d 
3e 
 
63 55 138-140d 
3f 
 
42 55 111-112d 
3g 
 
70 79 
166-167c 
Lit.:6 167-168 
3h 
 
44 
40b 
55 
57b 
111-112e 
3i 
 
78 70 164-166c 
3j 
 
69 
81b 
65 
84b 
107-108d 
3k 
 
85 88 186-187f 
3l 
 
71 60 135-136d 
a The reactions were performed using a Discover SP CEM microwave synthesizer with 0.325 
mmol or 3.25 mmol of ethyl 5-aminopyrazole-4-carboxylates 5 (R2 = Et) in 2.0 mL or 20 mL 
of aqueous 2M NaOH at 150 °C for 4 min.  
b The reaction was performed using a Discover SP CEM microwave synthesizer with 0.325 
mmol or 3.25 mmol of methyl 5-aminopyrazole-4-carboxylates 5 (R2 = Me) in 2.0 mL or 20 
mL of aqueous 2M NaOH at 150 °C for 4 min.  
Recrystallization solvents: c MeOH, d PhMe, eDMF & H2O, f MeCN 
  
2.2 X-ray crystallography of 5-amino-3-arylaminopyrazoles 3g and 3i  
The crystallographic asymmetric unit of 3g comprises two independent molecules, as shown 
in Figs. 2(a) and (b).  The pyrazole ring is planar exhibiting a r.m.s. deviation for the fitted 
atoms of 0.0021 Å [0.0044 Å for the second independent molecule].  The appended primary-
N3 and secondary-N5 amine atoms lie 0.073(3) and 0.072(3) Å out of and to the same side 
of the plane through the pyrazole ring [0.067(3) and 0.096(3) Å].  Twists in the molecule are 
noted as seen in the N1‒C5‒N5‒C51 torsion angle of -155.09(16) [-144.91(16)°] and 
manifested in dihedral angles between the rings of 30.89(8) cf. 37.45(7)° indicating an 
inclined relationship, see Fig. 2(c) for an overlay diagram of the two independent molecules. 
 
Figure 2. (a) and (b) The molecular structures of the first and second independent molecules 
comprising the asymmetric unit of 3g, respectively, showing atom labelling scheme and 70% 
anisotropic displacement parameters, and (c) an overlay diagram of the two independent 
molecules: red image, the molecule shown in (a) and green image, molecule in (b). The 
molecules are overlapped so that the pyrazole rings are coincident. 
Quite similar molecular features as described for 3g are also evident in the structure 
of 3i.  Here, four independent molecules comprise the crystallographic asymmetric unit.  
The first of these is illustrated in Fig. 3(a) and the remainder, i.e. molecules “a”, “b” and “c”, 
in ESI Fig. S1†.  As for 3g, the pyrazole ring is planar [r.m.s. deviations for the fitted atoms of 
0.0037, 0.0059, 0.0040 and 0.0049 Å for the four independent molecules, respectively].  
Differences between the molecules occurs in the relationships between appended primary-
N3 and secondary-N5 amine atoms to the pyrazole ring, lying to the opposite sides of the 
plane for the molecule shown in Fig. 3(a), i.e. 0.131(2) and 0.076(2) Å, and molecule “b” 
[0.125(2) and 0.074(2) Å], but, to the same side of the plane for molecules “a” [0.178(2) and 
0.058(2) Å] and “c” [0.171(2) and 0.056(2) Å].  The rings are inclined with respect to each 
other, forming dihedral angles of 50.22(5), 44.38(5), 50.35(5) and 44.29(5)°, respectively.  
Finally, the methoxy group is close to co-planar to the ring it is connected in two molecules 
while slightly twisted in the other two [C57‒O1‒C54‒C53 torsion angles: -4.0(2), 9.7(2), -
4.0(2) and 9.8(2)°, respectively].  The disparity in the dihedral angles between the rings and 
in the relative orientations of the methoxy groups are highlighted in the overlay diagram of 
the four independent molecules shown in Fig. 3(b). 
 
Figure 3. (a) The molecular structure of the first independent molecule of 3i showing atom 
labelling scheme and 70% anisotropic displacement parameters and (b) an overlay diagram 
of the four independent molecules comprising the asymmetric unit of 3i: red image, the 
molecule shown in (c), green image, molecule “a”, blue, molecule “b” and pink, molecule 
“c”. The molecules in are overlapped so that the pyrazole rings are coincident. 
 
As indicated above, the key differences between the structures of 3g and 3i rests in 
the adopted tautomeric form, with 3g being in the 3-N-(4-methylphenyl)-1H-pyrazole-3,5-
diamine form while 3i is in the 3-N-(4-methoxyphenyl)-2H-pyrazole-3,5-diamine form 
corresponding to the ring-nitrogen atoms being protonated at the N2 and N1 sites, 
respectively.  As anticipated, the different tautomers give rise to systematic differences in 
the geometric parameters characterising the ring.  Before detailing these, it is noted that 
only parameters for the molecules shown in Figs. 2(a) and 3(a) are discussed as for each 
structure, the parameters describing the other molecules comprising the asymmetric units 
are equal within experimental error to these, respectively.  In terms of bond lengths within 
the rings, the reorganisation of π-electron density giving rise to the different tautomers 
results in a decrease [1.345(2) cf. 1.3314(19) Å], increase [1.383(2) cf. 1.404(2) Å] and 
decrease [1.405(2) cf. 1.389(2) Å] in the N2‒C3, C3‒C4 and C4‒C5 bonds, respectively.  In 
terms of bond angles, the values of the N2‒N1‒C5 [103.46(13) cf. 111.84(11)°] and 
N1‒N2‒C3 [111.99(14) cf. 103.70(11)°] follow the trends expected for protonated ring 
nitrogen atoms.  The patterns noted in the molecular packing of 3g and 3i also confirm the 
assignments of the tautomeric forms of the five-membered rings. 
The molecular packing of 3g is replete with N‒H…N hydrogen bonding that results in 
the formation of a supramolecular layer; geometric details of the intermolecular 
interactions are given in ESI Table S1†.  Importantly and confirming the assignment of the 
1H-pyrazole tautomer, the pyrazole-N2 atom functions as a donor and the adjacent N1 
atom behaves as an acceptor for each molecule comprising the asymmetric unit. The 
independent molecules in 3g have distinctive hydrogen bonding patterns and there are 
extensive interactions between the independent molecules.  This point is illustrated by the 
bifurcated hydrogen bonds formed by the pyrazole-N2‒H atoms which interact with two 
pyrazole-N1a atoms of two different (and independent) molecules in contrast to the 
pyrazole-N2a-H atoms which form hydrogen bonds with each of the pyrazole-N1 and N2 
atoms of the same molecule; these pairs of contacts are indicated by “i” and “ii” in Fig. 4(a), 
respectively.  The amine-N3/N3a‒H atoms form hydrogen bonds with the pyrazole-N1a/N1 
atoms of the other independent molecules and are indicated with “iii” and “iv” in Fig. 4(a).  
The aforementioned hydrogen bonds serve to link molecules into a helical chain 
propagating along the b-axis.  The chains are assembled into a two-dimensional array 
parallel to (1 0 1) via interactions involving amine-N3/N3a-H atoms as the donors.  The 
amine-N3‒H atoms form hydrogen bonds with the pyrazole-N2a and amine-N3a atoms of 
different molecules, shown as “v” and “vi”.  By contrast, the amine-N3a‒H atoms do not 
form conventional hydrogen bonds with one of these participating in an amine-
N3a‒H…π(phenyl) interaction with the first independent molecule, indicated by “vii” in Fig. 
4(a) and shown in detail in Fig. 4(b), whereas the second amine-N3a‒H atom is separated 
2.70 Å from the amine-N3 atom.  Side-on and plan views of the supramolecular layer are 
shown in Fig. 4(c) and (d).  The most obvious contacts between the layers to consolidate the 
three-dimensional packing are methyl-C57‒H…π(C51a-C56a) interactions as highlighted in 
the unit cell diagram of ESI Fig. S2† from which it can be seen the phenyl groups project to 
either side of the layer. 
Despite there being four independent molecules in the crystal of 3i, to a first 
approximation the pattern of hydrogen bonding is relatively simple to describe; geometric 
details of the intermolecular interactions are given in ESI Table S2†.  Thus, for each molecule, 
the pyrazole-N1‒H forms a hydrogen bond to a pyrazole-N2 atom (thereby, confirming the 
2H-pyrazole tautomer) as does one of the two amine-N3‒H atoms so that each pyrazole-N2 
accepts two hydrogen bonds.  The amine-N5‒H atom of each molecule forms a hydrogen 
bond to the amine-N3 atom.  Some variation occurs for the second hydrogen atom of the 
amine-N3, being linked to amine-N5 in the cases of the molecule illustrated in Fig. 3(a) and 
molecule “b”.  For molecules “a” and “c”, this atom participates in an amine-
N3a‒H…π(pyrazole) interaction.  With the exception of the amine-N3b‒H…N2b(pyrazole) 
hydrogen bond, all connections occur between different independent molecules.  As for 3g, 
all of the hydrogen bonding in the crystal of 3i is focussed in specific regions of the crystal 
and lead to the formation of a supramolecular layers parallel to (1 1 0), as illustrated in Fig. 
5.  The phenyl groups project to either side of the layer and interact via phenyl-
C‒H…π(phenyl) interactions.  Layers stack along the c-axis and are separated by hydrophobic 
interactions; the closest O…H contact between layers (2.88 Å) is well beyond the sum of their 
van der Waals radii (2.72 Å).  A view of the unit cell contents is shown in ESI Fig. S3†. 
It should be noted that the intermolecular interactions in crystals are critical for the 
stabilisation of the observed tautomeric forms; therefore, these preferences cannot be 
directly extrapolated to tautomeric equilibria in solutions.  
  
Figure 4. Supramolecular association in the crystal of 3g: (a) N‒H…N hydrogen bonding (see 
ESI Fig. S2 and Table S1†) leading to a supramolecular chain aligned along the b-axis, (b) 
detail of the amine-N3a‒H…π(phenyl) interaction, (c) a side-on view of the supramolecular 
layer parallel to (1 0 1) and (d) a plan view of the layer (amine-N3a‒H…π(phenyl) interactions 
are not shown).  Please refer to the text for an explanation of “i”-“vii” in (a)-(c).  In all 
images, non-participating hydrogen atoms have been removed and in (a) and (d), only the 
ipso-carbon atom of the phenyl rings are shown. 
 
Figure 5. Supramolecular association in the crystal of 3i: a view of the supramolecular layer 
parallel to (1 1 0).  The N‒H…N hydrogen bonding and N‒H…π(pyrazole) interactions (see ESI 
Fig. S3 and Table S2†) are shown as orange and blue dashed lines, respectively.  Only acidic 
hydrogen atoms and ipso-carbon atoms of the phenyl groups are shown. 
 
3. Conclusion 
A new efficient method for the synthesis of 3(5)-amino-substituted 5(3)-aminopyrazoles 3 
was developed using hydrolytic decarboxylation of the ester group on the corresponding 
3,5-diaminopyrazole-4-carboxylates 5 under microwave irradiation.  The method was 
proven to be practical due to operational simplicity, short reaction time, good 
reproducibility and scalability.  The X-ray crystallography performed on two representative 
aminopyrazoles 3g and 3i identified, on the basis of crystallographic refinement, systematic 
variations of key geometric parameters and intermolecular interactions, the presence of 
two different tautomers: the 1H- and 2H-pyrazole, respectively.  
  
4. Experimental 
4.1 General information 
Melting points (uncorrected) were determined on a Stuart™ SMP40 automatic melting point 
apparatus.  1H and 13C NMR spectra were recorded on a Bruker Fourier NMR spectrometer 
(300 MHz) using DMSO-d6 as a solvent and TMS as an internal reference.  IR spectra were 
recorded in KBr pellets using a Varian 640-IR spectrophotometer.  Microwave-assisted 
reactions were carried out in the closed vessel focused single mode using a Discover SP 
microwave synthesizer (CEM, USA) monitoring reaction temperature by the equipped IR 
sensor.  For the method validation, the model reaction was also carried out using 
Monowave 400 and Monowave 50 (Anton Paar, Austria) reactors.  
 
4.2 General method for the microwave-assisted synthesis of 3-amino-substituted 5-
aminopyrazoles 3 
An ethyl 3,5-diaminopyrazole-4-carboxylate (5) (0.325 mmol) in 2M aqueous solution of 
NaOH (2.0 mL) was irradiated in a 10 mL seamless pressure vial using microwave system 
operating at maximal microwave power up to 150 W (Discover SP, CEM) at 150 °C for 4 min. 
After cooling, the precipitated product 3 was filtered and washed with cold water and 
recrystallised from a suitable solvent. The reaction was also replicated in an increase scale of 
ethyl 3,5-diaminopyrazole-4-carboxylates (5) (3.25 mmol) in aqueous 2M NaOH (20 mL). The 
same procedure was also effectively applied using the selected methyl 3,5-diaminopyrazole-
4-carboxylates (5) as the starting material.  
4.2.1 5-Amino-3-phenylaminopyrazole (3a) 
Yield (0.325 / 3.25 mmol scale): 81% / 68% (74% / 76% from the methyl ester); mp 166-
168 °C (MeOH), lit.:6 166 °C;  1H NMR (300 MHz, DMSO-d6): δ 4.88-4.91 (3H, br s, NH2 and H-
4), 6.63 (1H, t, 3J = 7.1 Hz, H-4′), 7.11 (2H, t, 3J = 7.8 Hz, H-3′ and H-5′), 7.29 (2H, d, 3J = 6.0 
Hz, H-2′ and H-6′), 8.01 (1H, br s, NH), 10.47 (1H, br s, NH); 13C NMR (75 MHz, DMSO-d6): δ 
77.2 (C-4), 114.7 (C-2′ and C-6′), 117.2 (C-4′), 128.5 (C-3′ and C-5′), 144.2 (C-1′), 147.9 (C-3), 
151.1 (C-5). IR (KBr): ν 3359 (N-H), 3310 (N-H), 3148 (C-H), 1618, 1581, 1451, 1276, 1173, 
1093, 1005 cm-1. Anal. calcd. for C9H10N4: C, 62.05; H, 5.8; N, 32.2. Found: C, 61.9; H, 6.0; N, 
31.9. 
4.2.2 5-Amino-3-(4-fluorophenyl)aminopyrazole (3b) 
Yield (0.325 / 3.25 mmol scale): 61% / 68%; mp 165-167 °C (MeOH); 1H NMR (300 MHz, 
DMSO-d6): δ 4.88 (3H, br s, NH2 and H-4), 6.95 (2H, dd, 3JHH = 8.9 Hz, 2JHF = 8.9 Hz, H-3′ and 
H-5′), 7.31 (2H, br s, H-2′ and H-6′), 8.04 (1H, br s, NH), 10.46 (1H, br s, NH); 13C NMR (75 
MHz, DMSO-d6): δ 76.7 (C-4), 114.7 (d, 2JCF = 21.7 Hz, C-3′ and C-5′), 115.6 (d, 3JCF = 7.24 Hz, 
C-2′ and C-6′), 140.7 (d, 4JCF = 2.2 Hz, C-1′), 147.9 (C-3), 151.2 (C-5), 154.7 (d, 1JCF = 233.1 Hz, 
C-4′). IR (KBr): ν 3359 (N-H), 3312 (N-H), 3143 (C-H), 1624, 1586, 1502, 1278, 1238, 1101, 
1005 cm-1. Anal. calcd. for C9H9FN4: C, 56.2; H, 4.7; N, 29.15. Found: C, 56.05; H, 4.9; N, 28.0.  
4.2.3 5-amino-3-(3-chlorophenyl)aminopyrazole (3c) 
Yield (0.325 / 3.25 mmol scale): 60% / 47%; mp 58-60 °C (MeOH); 1H NMR (300 MHz, DMSO-
d6): δ 4.90-4.95 (3H, br s, NH2 and H-4), 6.64-6.67 (1H, m, H-4′), 7.10-7.15 (2H, m, H-5′ and 
H-6′), 7.62 (1H, br s, H-2′), 8.36 (1H, br s, NH), 10.58 (1H, br s, NH); 13C NMR (75 MHz, 
DMSO-d6): δ 77.1 (C-4), 113.3 (C-6′), 113.8 (C-2′), 116.5 (C-4′), 129.8 (C-5′), 133.1 (C-3′), 
145.4 (C-1′), 147.9 (C-3), 150.5 (C-5). IR (KBr): ν 3359 (N-H), 3288 (N-H), 3143 (C-H), 1630, 
1585, 1483, 1422, 1257, 1093, 1010 cm-1. Anal. calcd. for C9H9ClN4: C, 51.8; H, 4.35; N, 
26.85. Found: C, 51.7; H, 4.5; N, 26.7. 
4.2.4 5-Amino-3-(4-chlorophenyl)aminopyrazole (3d) 
Yield (0.325 / 3.25 mmol scale): 69% / 57%; mp 169-171 °C (PhMe); 1H NMR (300 MHz, 
DMSO-d6): δ 4.89-4.91 (3H, br s, NH2 and H-4), 7.14 (2H, d, 3J = 8.8 Hz, H-3′ and H-5′), 7.34 
(2H, d, 3J = 7.4 Hz, H-2′ and H-6′), 8.24 (1H, br s, NH), 10.53 (1H, br s, NH); 13C NMR (75 MHz, 
DMSO-d6): δ 77.0 (C-4), 116.0 (C-2′ and C-6′), 120.3 (C-4′), 128.1 (C-3′ and C-5′), 142.9 (C-1′), 
147.9 (C-3), 150.7 (C-5). IR (KBr): ν 3453 (N-H), 3367 (N-H), 3282 (C-H), 1623, 1595, 1548, 
1472, 1249, 1177, 1088 cm-1. Anal. calcd. for C9H9ClN4: C, 51.8; H, 4.35; N, 26.85. Found: C, 
51.6; H, 4.5; N, 26.6.  
4.2.5 5-Amino-3-(3-iodophenyl)aminopyrazole (3e) 
Yield (0.325 / 3.25 mmol scale): 63% / 55%; mp 138-140 °C (PhMe); 1H NMR (300 MHz, 
DMSO-d6): δ 4.89-4.93 (3H, br s, NH2 and H-4), 6.87-6.92 (1H, m, H-5′), 6.95-6.99 (1H, m, H-
4′), 7.16 (1H, d, 3J = 6.8 Hz, H-6′), 7.90 (1H, br s, H-2′), 8.25 (1H, br s, NH), 10.57 (1H, br s, 
NH); 13C NMR (75 MHz, DMSO-d6): δ 77.1 (C-4), 94.9 (C-3′), 114.1 (C-6′), 122.5 (C-2′), 125.5 
(C-4′), 130.4 (C-5′), 145.4 (C-1′), 147.9 (C-3), 150.4 (C-5). IR (KBr): ν 3383 (N-H), 3304 (N-H), 
3160 (C-H), 1573, 1475, 1395, 1269, 1166, 1095, 1063 cm-1. Anal. calcd. for C9H9IN4: C, 36.0; 
H, 3.0; N, 18.7. Found: C, 35.9; H, 3.2; N, 18.5.  
4.2.6 5-Amino-3-(3-methylphenyl)aminopyrazole (3f) 
Yield (0.325 / 3.25 mmol scale): 42% / 55%; mp 111-112 °C (PhMe); 1H NMR (300 MHz, 
DMSO-d6): δ 2.20 (3H, s, CH3), 4.86-4.91 (3H, br s, NH2 and H-4), 6.46 (1H, d, 3J = 6.8 Hz, H-
4′), 6.96-7.13 (3H, m, H-2′, H-5′ and H-6′), 7.92 (1H, br s, NH), 10.46 (1H, br s, NH); 13C NMR 
(75 MHz, DMSO-d6): δ 21.3 (CH3), 77.2 (C-4), 111.9 (C-6′), 115.1 (C-2′), 118.1 (C-4′), 128.3 (C-
5′), 137.3 (C-3′), 144.1 (C-1′), 147.8 (C-3), 151.2 (C-5). IR (KBr): ν 3400 (N-H), 3302 (N-H), 
3235 (C-H), 1581, 1493, 1435, 1282, 1165, 1071, 1000 cm-1. Anal. calcd. for C10H12N4: C, 63.8; 
H, 6.4; N, 29.8. Found: C, 63.65; H, 6.6; N, 29.6.  
4.2.7 5-Amino-3-(4-methylphenyl)aminopyrazole (3g) 
Yield (0.325 / 3.25 mmol scale): 70% / 79%; mp 166-167 °C (MeOH), lit.:6 167-168 °C; 1H 
NMR (300 MHz, DMSO-d6): δ 2.17 (3H, s, CH3), 4.86 (3H, br s, NH2 and H-4), 6.92 (2H, d, 3J = 
8.3 Hz, H-3′ and H-5′), 7.19 (2H, br s, H-2′ and H-6′), 7.86 (1H, br s, NH), 10.41 (1H, br s, NH); 
13C NMR (75 MHz, DMSO-d6): δ 20.1 (CH3), 76.9 (C-4), 114.7 (C-2′ and C-6′), 125.5 (C-4′), 
128.8 (C-3′ and C-5′), 141.7 (C-1′), 147.8 (C-3), 151.4 (C-5). IR (KBr): ν 3399 (N-H), 3319 (N-H), 
3189 (C-H), 1616, 1580, 1514, 1298, 1180, 1180, 1100 cm-1. Anal. calcd. for C10H12N4: C, 63.8; 
H, 6.4; N, 29.8. Found: C, 63.7; H, 6.6; N, 29.6.  
4.2.8 5-Amino-3-(2-methoxyphenyl)aminopyrazole (3h) 
Yield (0.325 / 3.25 mmol scale): 44% / 55% (40% / 57% from methyl 5-aminopyrazole-4-
carboxylate); mp 111-112 °C (DMF &H2O); 1H NMR (300 MHz, DMSO-d6): δ 3.82 (3H, s, 
OCH3), 4.89 (2H, br s, NH2), 5.07 (1H, br s, H-4), 6.67 (1H, t, 3J = 7.3 Hz , H-5′), 6.79 (1H, t, 3J = 
7.3 Hz, H-4′), 6.87 (1H, d, 3J = 7.7 Hz, H-3′), 6.99 (1H, br s, NH), 7.92 (1H, d, 3J = 7.9 Hz, H-6′), 
10.51 (1H, br s, NH); 13C NMR (75 MHz, DMSO-d6): δ 55.4 (OCH3), 77.7 (C-4), 109.9 (C-3′), 
114.0 (C-6′), 117.4 (C-4′), 120.6 (C-5′), 132.9 (C-1′), 146.1 (C-2′), 147.8 (C-3), 150.8 (C-5). IR 
(KBr): ν 3423 (N-H), 3339 (N-H), 3310 (C-H), 1600, 1578, 1460, 1296, 1251, 1114, 1023 cm-1. 
Anal. calcd. for C10H12N4O: C, 58.8; H, 5.9; N, 27.4. Found: C, 58.7; H, 6.1; N, 27.3. 
4.2.9 5-Amino-3-(4-methoxyphenyl)aminopyrazole (3i) 
Yield (0.325 / 3.25 mmol scale): 78% / 70%; mp 164-166 °C (MeOH); 1H NMR (300 MHz, 
DMSO-d6): δ 3.69 (3H, s, OCH3), 4.85 (3H, br s, NH2 and H-4), 6.74 (2H, d, 3J = 8.8 Hz, H-3′ and 
H-5′), 7.24 (2H, d, 3J = 7.4 Hz, H-2′ and H-6′), 7.74 (1H, br s, NH), 10.36 (1H, br s, NH); 13C 
NMR (75 MHz, DMSO-d6): δ 55.1 (OCH3), 76.5 (C-4), 113.9 (C-3′ and C-5′), 115.9 (C-2′ and C-
6′), 138.0 (C-1′), 147.8 (C-3), 151.4 (C-5), 151.7 (C-4′). IR (KBr): ν 3395 (N-H), 3288 (N-H), 
3148 (C-H), 1609, 1583, 1442, 1248, 1178, 1108, 1036 cm-1. Anal. calcd. for C10H12N4O: C, 
58.8; H, 5.9; N, 27.4. Found: C, 58.7; H, 6.1; N, 27.2. 
4.2.10 5-Amino-3-(4-trifluoromethoxyphenyl)aminopyrazole (3j) 
Yield (0.325 / 3.25 mmol scale): 69% / 65% (81% / 84% from methyl 5-aminopyrazole-4-
carboxylate); mp 107-108 °C (PhMe); 1H NMR (300 MHz, DMSO-d6): δ 4.91 (3H, br s, NH2 and 
H-4), 7.11 (2H, d, 3J = 8.6 Hz, H-3′ and H-5′), 7.38 (2H, d, 3J = 7.1, H-2′ and H-6′), 8.31 (1H, br 
s, NH), 10.55 (1H, br s, NH); 13C NMR (75 MHz, DMSO-d6): δ 77.0 (C-4), 115.4 (C-2′ and C-6′), 
120.3 (q, 1JCF = 250.6 Hz, CF3), 121.5 (C-3′ and C-5′), 139.3 (q, 3JCF = 2.5 Hz, C-4′), 143.4 (C-1′), 
147.9 (C-3), 150.7 (C-5). IR (KBr): ν 3400 (N-H), 3295 (N-H), 3209 (C-H), 1583, 1513, 1324, 
1219, 1175, 1003 cm-1. Anal. calcd. for C10H9F3N4O: C, 46.5; H, 3.5; N, 21.7. Found: C, 46.4; H, 
3.6; N, 21.6. 
4.2.11 5-Amino-3-(4-isopropylphenyl)aminopyrazole (3k) 
Yield (0.325 / 3.25 mmol scale): 85% / 88%; mp 186-187 °C (MeCN); 1H NMR (300 MHz, 
DMSO-d6): δ 1.15 (6H, d, 3J = 6.9 Hz , (CH3)2), 2.75 (1H, m, 3J = 6.9 Hz , CH), 4.85-4.89 (3H, br 
s, NH2 and H-4), 6.99 (2H, d, 3J = 8.5 Hz, H-3′ and H-5′), 7.17 (2H, d, 3J = 7.4 Hz, H-2′ and H-6′), 
7.86 (1H, br s, NH), 10.43 (1H, br s, NH); 13C NMR (75 MHz, DMSO-d6): δ 24.1 (2 x CH3), 32.49 
(CH), 76.90 (C-4), 114.7 (C-2′ and C-6′), 126.1 (C-3′ and C-5′), 137.0 (C-4′), 142.0 (C-1′), 147.8 
(C-3), 151.4 (C-5). IR (KBr): ν 3395 (N-H), 3312 (N-H), 2957 (C-H), 1618, 1597, 1552, 1289, 
1187, 1187, 1103 cm-1. Anal. calcd. for C12H16N4: C, 66.6; H, 7.5; N, 25.9. Found: C, 66.5; H, 
7.5; N, 25.8. 
4.2.12 5-Amino-3-phenethylaminopyrazole (3l) 
Yield (0.325 / 3.25 mmol scale): 71% / 60%; mp 135-136 °C (PhMe); 1H NMR (300 MHz, 
DMSO-d6): δ 2.77 (2H, t, 3J = 7.4 Hz, CH2), 3.14 (2H, q, 3J = 7.0 Hz, CH2), 4.15* and 4.69 (2H, 
br s, NH2), 4.62 (1H, s, H-4), 4.69 and 5.14* (1H, br s, NH), 7.12-7.33 (5H, m, Ph), 10.02 (1H, 
br s, NH); 13C NMR (75 MHz, DMSO-d6): δ 35.6 (CH2), 45.6 (CH2), 74.7 (C-4), 125.7 (C-4′), 
128.1 (C-2′ and C-6′), 128.5 (C-3′ and C-5′), 139.8* and 140.3 (C-1′), 148.3 and 150.0* (C-3), 
154.9* and 156.3 (C-5); * - signals of the minor tautomer. IR (KBr): ν 3382 (N-H), 3303 (N-H), 
3243 (C-H), 1590, 1559, 1499, 1371, 1187, 1099, 1061 cm-1. Anal. calcd. for C11H14N4: C, 65.3; 
H, 7.0; N, 27.7. Found: C, 65.2; H, 7.2; N, 27.45.  
 
4.3 Synthesis of 5-amino-3-phenylaminopyrazole (3a) via heating in a sealed vessel. 
An ethyl 5-amino-3-phenylaminopyrazole-4-carboxylate (5a, 80 mg, 0.325 mmol) in 2M 
aqueous solution of NaOH (2 mL) was heated in a 10 mL seamless pressure vial in an 
enclosed system (Monowave 50, Anton Paar) at 150 °C for 4 min.  After cooling, the 
precipitate was filtered to obtain a compound, which was identical to 3a prepared under 
microwave irradiation. Yield 75%. 
 
4.4 X-ray crystallographic analysis 
Intensity data for 3g and 3i were measured for colourless crystals (3g: 0.03 x 0.12 x 0.23 
mm; 3i: 0.04 x 0.11 x 0.21 mm) at 100 K on an Rigaku/Oxford Diffraction XtaLAB Synergy 
diffractometer (Dualflex, AtlasS2) fitted with CuK radiation (λ = 1.54178 Å) so that θmax = 
67.1°.  Data reduction and Gaussian absorption corrections were by standard methods.12  
The structures were solved by direct methods13 and refined14 on F2 with anisotropic 
displacement parameters and C-bound H atoms included in the riding model approximation.  
The N-bound H atoms were refined freely.  A weighting scheme of the form w = 1/[2(Fo2) + 
(aP)2 + bP] where P = (Fo2 + 2Fc2)/3) was introduced in each case.  In the refinement of 3g, 
two reflections, i.e. (2 0 4) and (3 0 1), were removed from the final cycles of refinement 
owing to poor agreement.  The molecular structure diagrams showing 70% probability 
displacement ellipsoids were generated by ORTEP for Windows15 and the packing diagrams 
with DIAMOND.16 Additional data analysis was made with PLATON.17 
 
4.4.1 Crystal data for 3g: C10H12N4, M = 188.24, monoclinic, P21/n, a = 18.0137(5), b = 
6.15230(10), c = 18.2375(5) Å,  = 114.056(3)°, V = 1845.64(9) Å3, Z = 8, Dx = 1.355 g cm-3, 
F(000) = 800,  = 0.693 mm-1, no. reflns meas. = 23354, no. unique reflns = 3290 (Rint = 
0.047), no. reflns with I ≥ 2(I) = 2949, no. parameters = 287, R(obs. data) = 0.045, a and b in 
weighting scheme = 0.047 and 1.490, wR2(all data) = 0.111. CCDC deposition number: 
1866662. 
 
4.4.2 Crystal data for 3i: C10H12N4O, M = 204.24, triclinic, P1¯, a = 9.6175(2), b = 10.4055(2), c 
= 20.1541(3) Å,  = 85.3860(10),  = 83.139(2),  = 89.982(2)°, V = 1995.90(6) Å3, Z = 8, Dx = 
1.359 g cm-3, F(000) = 864,  = 0.763 mm-1, no. reflns meas. = 46475, no. unique reflns = 
7127 (Rint = 0.042), no. reflns with I ≥ 2(I) = 6104, no. parameters = 609, R(obs. data) = 
0.046, a and b in weighting scheme = 0.095 and 0.536, wR2(all data) = 0.139. CCDC 
deposition number: 1866664. 
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